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Aging and dementia 
a b s t r a c t 
The mismatch in the spatial resolution of Arterial Spin Labeling (ASL) MRI perfusion images and the anatomy 
of functionally distinct tissues in the brain leads to a partial volume effect (PVE), which in turn confounds the 
estimation of perfusion into a specific tissue of interest such as gray or white matter. This confound occurs 
because the image voxels contain a mixture of tissues with disparate perfusion properties, leading to estimated 
perfusion values that reflect primarily the volume proportions of tissues in the voxel rather than the perfusion of 
any particular tissue of interest within that volume. It is already recognized that PVE influences studies of brain 
perfusion, and that its effect might be even more evident in studies where changes in perfusion are co-incident 
with alterations in brain structure, such as studies involving a comparison between an atrophic patient population 
vs control subjects, or studies comparing subjects over a wide range of ages. However, the application of PVE 
correction (PVEc) is currently limited and the employed methodologies remain inconsistent. 
In this article, we outline the influence of PVE in ASL measurements of perfusion, explain the main principles 
of PVEc, and provide a critique of the current state of the art for the use of such methods. Furthermore, we examine 
the current use of PVEc in perfusion studies and whether there is evidence to support its wider adoption. 
We conclude that there is sound theoretical motivation for the use of PVEc alongside conventional, ‘uncor- 
rected’, images, and encourage such combined reporting. Methods for PVEc are now available within standard 
neuroimaging toolboxes, which makes our recommendation straightforward to implement. However, there is 






















The Partial Volume Effect (PVE) is a widely recognized phenomenon
n medical imaging, reflecting the fact that the spatial resolutions of the
mages are lower than the variations in the anatomy of the tissues they
eek to capture. For example, even ‘high’ resolution anatomical MRI,
ith voxels sizes smaller than 1 mm isotropic, will contain many voxels
hich lie across a boundary between tissues identified as gray matter∗ Corresponding author at: University of Nottingham, Beacon Hub Offices, A floor,
E-mail address: michael.chappell@nottingham.ac.uk (M.A. Chappell). 
ttps://doi.org/10.1016/j.neuroimage.2021.118236 . 
eceived 19 February 2021; Received in revised form 25 May 2021; Accepted 2 June
vailable online 4 June 2021. 
053-8119/© 2021 The Author(s). Published by Elsevier Inc. This is an open access a Medical School, QMC, Nottingham, NG7 2UH, UK. 
GM), white matter (WM), and cerebral spinal fluid (CSF). Whilst PVE is
idely acknowledged, its influence on MRI techniques that seek to de-
ive quantitative measurements of physiological processes in the brain,
uch as perfusion, is often neglected. This article considers the effect
f partial voluming on quantitative perfusion measurements using Ar-
erial Spin Labeling (ASL) MRI and whether correction for this effect is
arranted given the algorithms currently available. Many of these ar-
uments are shared with other perfusion modalities, such as dynamic 2021 
rticle under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ ) 































































Fig. 1. Comparing an ASL perfusion image (left) with the estimated partial vol- 
umes (PV) of gray matter in the same individual on a matched imaging grid 
(right). Estimated PV of gray matter is obtained by down-sampling a GM seg- 











































r  usceptibility contrast perfusion MRI, O 15 -H 2 O PET, CT perfusion, and
losely related methods like FDG-PET. There are modality specific in-
uences, however, which means that the impact and appropriateness of
orrection for PVE may be different for each modality. For example, the
ifference in the width of the point spread function between PET and
RI introduces an additional source of partial voluming in PET appli-
ations ( Greve et al., 2016 ). 
The aim of this article is firstly to outline the influence of PVE in ASL
easurements of tissue-specific perfusion and the implications this has
or analysis using ASL perfusion measurements. We then seek to make
ecommendations for how to control for the effects of PVE, including
n overview of the main principles of partial volume correction (PVEc),
nd a critique of the current state of the art for the use of such methods.
urthermore, we examine the current use of PVEc in perfusion studies
nd whether there is evidence to support its wider adoption. 
. The sources of partial volume effects in perfusion 
easurements 
Interest in hemodynamic and perfusion imaging has grown signifi-
antly in the last decade since changes to perfusion and microvascula-
ure have been found to occur earlier than structural changes in sev-
ral disease processes ( Cada et al., 2000 ; Iturria-Medina et al., 2016 ;
ong et al., 1999 ). As such, perfusion imaging is playing an increasingly
mportant role in understanding and management of diseases such as
troke, cancer, Alzheimer’s, Parkinson’s, dementia with Lewy bodies,
ronto-temporal dementia, and other vascular and neurodegenerative
rain diseases ( Grade et al., 2015 ; Telischak et al., 2014 ). ASL is partic-
larly well suited for clinical research because it is non-invasive and con-
ensus on robust and reliable acquisition is now available ( Alsop et al.,
015 ). This is evidenced by the steady increase in the number of publi-
ations employing ASL, including a growing number where it is used to
mage perfusion in a wide range of clinical applications. 1 
The typical definition of perfusion in physiology is the process of
elivering blood to the capillary bed in a tissue. Perfusion is important
ecause it relates directly to the function of the vascular system to de-
iver nutrients to the tissue and remove waste. The seminal work by
ety and Schmidt (1948 ) introduced the concept of measuring the per-
usion of a whole organ and the units of perfusion that are still widely
sed to this day: ml blood/ 100 g tissue/ min. Subsequent developments
ave aimed to ‘zoom in’ and measure not only the total blood flow to
n organ, but also the distribution of blood delivery within an organ.
ence, the goal of current perfusion imaging techniques is to provide
patially resolved maps of capillary blood delivery within organs which
re subsequently used to quantify perfusion within individually defined
egions of interest and/or voxels. However, a voxel is not an anatom-
cally or physiologically meaningful volume and there is no guarantee
hat perfusion measured in one voxel in one region of an organ in one
ubject can be meaningfully compared to a different voxel in a different
egion and/or a different individual. For brain perfusion imaging, it has
ecome conventional to separate cortical gray from white matter perfu-
ion in ASL measurements, reflecting the gross differences in perfusion
and other hemodynamic properties) between these two anatomically
ifferent tissues as well as the different roles they play in normal brain
unction and disease. 
ASL is typically imaged with a voxel volume of ~ 3.5 × 3.5 × 5 mm 3 ,
hich is more than an order of magnitude lower than that of anatomical
RI. This volume is ‘large’ when compared to spatial variations of tissue
ontent in the brain. For example, the average thickness of the cortex
n young healthy adults has been found to be ~ 2.5 mm ( Fischl and
ale, 2000 ). It is, therefore, inevitable that most ASL voxels will con-
ain a mixture of the different constituent tissues: primarily GM, WM and
SF. It is generally accepted that GM has somewhere between 2 and 51 A pubmed search with ‘Arterial Spin Labeling MRI’ returns over 300 publi- 




2 imes the perfusion of WM, according to PET studies ( Donahue et al.,
006 ; Huang et al., 1983 ), whilst CSF is not perfused. The perfusion
alues measured by ASL in any given voxel will inherently reflect a
eighted average of the perfusion of the mixture of tissues present in
hat voxel. A comparatively modest partial volume mixture of 80% GM
nd 20% CSF, as might survive most thresholding criteria in a group
nalysis and thus count as a ‘GM voxel’, would give rise to an underes-
imate of perfusion by ~24% in theory ( Asllani et al., 2008 ). Even for
ealthy young brains, most imaged voxels present a mixture of signals
rom at least two different tissues. This effect will be more pronounced
n aging and diseased brains due to atrophy and tissue damage. 
Fig. 1 illustrates the influence of PVE on ASL perfusion images, com-
aring a perfusion-weighted image to a down-sampled map of GM par-
ial volumes segmented from a T1-weighted anatomical image in the
ame individual. The measured ASL perfusion image reflects many of
he spatial characteristics of the GM PV image, indicating the degree to
hich structural information directly influences the appearance of the
erfusion image. The ASL perfusion image might thus be described as a
tructural image with perfusion information modulated on top, or that
he brain anatomy is ‘shining through’ the perfusion. 
Arguably, PVE in ASL images may not be obviously problematic
hen images are being visually read for the presence of substantial re-
ions of hyper- or hypperfusion, such as in stroke and brain tumors. In
uch situation it is sufficient to examine the overall perfusion within vox-
ls. However, PVE could be substantially misleading for quantification
f perfusion when examining differences of perfusion between individu-
ls, e.g., in a study population, or when seeking to detect subtle changes
n perfusion, such as in neurodegenerative diseases (for example, hip-
ocampal flow in aging and Alzheimer’s disease) or diaschisis effects
n stroke. In such cases, genuine perfusion differences or changes may
e confused for, or masked by, differences or changes in PVE between
orresponding voxels in the same anatomical location. Changes in PVE
re expected to be exacerbated in aging and dementia populations due
o atrophy and other disease-related changes in the brain anatomy. 
Whilst various methods have been developed for the correction
f PVE (PVEc) in ASL, ( Ahlgren et al., 2014 ; Asllani et al., 2008 ;
happell et al., 2011 ; Johnson et al., 2005 ; Kandel et al., 2015 ;
iang et al., 2013 ; Petr et al., 2013 ; Wiersma et al., 2006 ) with varying
evels of sophistication and assumptions on perfusion in cerebral tissue
these are reviewed in more depth in ‘Correcting for Partial Volume Ef-
ects‘ in the Supplementary Materials), no consensus has emerged on the
est method to use, despite comparative studies examining their theo-
etical and practical performance ( Petr et al., 2018 ; Zhao et al., 2017 ).
nd, there remain issues around the estimation of tissue partial volumes
sed in all correction algorithms mentioned above (for more detail see
Confounds for PVEc’ in the Supplementary Materials). 























































































































Like many functional MRI techniques, ASL resolution is chosen to
chieve sufficient SNR by sampling from larger voxel volumes than used
n anatomical imaging. PVE will have less of an impact at higher spa-
ial resolution, hence ( Donahue et al., 2006 ) found an increase in GM
erfusion of 10–20% in high (2.5 × 2.5 × 3.0 mm 3 ) resolution ASL
hat they attributed to a reduction in PVE. Higher resolution ASL data
ave been made possible by advances in technology including 3D or Si-
ultaneous Multi-Slice (SMS) readouts. For example, the Human Con-
ectome Project Ageing and Development cohorts acquired ASL with
oxel dimensions 2.5 mm isotropic in a 5:29 min acquisition using
MS ( Harms et al., 2018 ; Li et al., 2015 ). Despite this, PVE in such
igh resolution ASL may still be substantial, especially in older cohorts
 Álvarez et al., 2019 ). ASL performed at higher magnetic field ( > 3T),
xploiting the inherent enhancement in SNR and the further SNR ben-
fits for ASL imaging of longer T1 times potentially, offers higher res-
lution, e.g., ( Álvarez et al., 2019 ; Bause et al., 2016 ; Luh et al., 2013 ;
uo et al., 2013 ), and might enable sub-millimeter voxel dimensions
lbeit with limited brain coverage ( Huber et al., 2019 ). However, the
dvanced technology needed to achieve high resolution are not widely
vailable and not accessible to many clinical studies. 
PET imaging is the other major research field in which PVE has been
xamined, having similar motivation to ASL investigations due to the
ow imaging resolution compared to brain anatomy ( Erlandsson et al.,
012 ; Greve et al., 2016 ; Thomas et al., 2016 ). PET researchers have
ikewise investigated correction approaches, some of which have been
he basis for or were based upon those used in ASL. However, at this
oint there has not been widespread adoption of PVEc for PET, partially
ecause availability of high-resolution structural brain images is not as
outine for PET as for ASL. Furthermore, the relationship between tis-
ue type and PET tracer signal is potentially more complex than for ASL
erfusion, since the influence of the differences in point spread func-
ion between the anatomical and PET imaging makes a more substan-
ial contribution to PVE on top of effects arising from mixing different
issue types within a voxel (commonly termed in the PET literature as
he Tissue Fraction Effect). The influence of the PSF in ASL PVE is typi-
ally ignored, though there are a few studies that have examined or at-
empted to correct for PSF related effects in ASL ( Chappell et al., 2011 ;
hao et al., 2017 ). The combination of tissue mixing and PSF are found
n other comparatively low resolution non-cartesian MRI methods, such
s 23 Na imaging, where PVEc methods have also been used ( Kim et al.,
021 ; Niesporek et al., 2015 ). 
There is a sound theoretical foundation to suggest that accounting
or PVE when using ASL will provide greater insight into the underly-
ng physiology beyond what is possible with existing perfusion images.
he evidence that it makes a practical difference is, however, currently
imited, not least because of the lack of studies employing methods to
orrect for PVE and a lack of consistency between those that do. We
ave identified three areas in which PVE in ASL has an impact, and in
hich some form of correction may be warranted: 
• Quantification of perfusion in regions of interest, 
• Detecting voxelwise perfusion differences between groups, 
• Detecting genuine perfusion changes when accompanied by atrophy.
In the rest of this article, we highlight the impact of PVE in these
ases and suggest ways forward for the community when considering the
ole of managing or correcting for PVE. In doing so we seek to guide the
ommunity to a more consistent approach, as well as motivate further
wareness and focused research in this area. 
. The impact of PVE in ASL studies 
In this section we examine the influence of PVE when ASL is used to
xamine perfusion within or between groups of individuals in a study,
eeking to highlight the specific issues that arise from PVE in common
pplications of ASL. 3 .1. Influence of PVE on quantitative perfusion in regions of interest (ROIs)
In ASL studies, as with many fMRI studies, it is common to calcu-
ate perfusion in ROIs, including the calculation within a whole-brain
OI as well as anatomical ROIs defined from an atlas. Quite apart from
he usual issues around differences in resolution between the data and
he space in which ROIs might be defined, for ASL, PVE has important
onsequences for quantitative perfusion measurement from an ROI , since
he tissue content of the ROI will directly affect the apparent perfusion
alue returned. 
The consequences of PVE in ROI-based quantification are: 
• systematic under-estimation of cortical GM perfusion due to the mix-
ture of tissues present within the ROI; 
• increased variability between individuals due to inherent differences
in the proportions of different tissues within the ROI due to indi-
vidual anatomy and position of the brain relative to the acquisition
grid. This will reduce the statistical power to detect differences in
perfusion, and will increase the reported between-subject variabil-
ity beyond that due to genuine physiological variation; 
• increased variability between studies due to methodological differ-
ences arising from both variation in acquisition, e.g. the resolution
used, leading to variation in the magnitude of the intrinsic PVE; and
from variation in analysis, e.g. how ROI are defined and whether
they are applied in the native space of the ASL data or in template
space. 
It is common for ASL studies to report whole-brain mean perfusion
s a single representative metric from each individual. Since GM is the
ost highly perfused tissue in the brain, and hence is the easiest within
hich to detect perfusion using ASL, as well as being the tissue in which
erfusion is likely to vary in most functional studies and many patholo-
ies, it is generally accepted that this ROI should be restricted only to
he GM and thus the whole-brain GM mean perfusion is reported. We be-
ieve it is likely that a measure of whole-brain GM perfusion will become
he de facto imaging derived phenotype ( Elliott et al., 2018 ; Miller et al.,
016 ) from ASL. 
With typical ASL resolution it is almost impossible to define a ‘pure’
M ROI: the number of voxels that do not have some contamination
ith WM or CSF is very limited. The influence of PVE on whole-brain
M mean perfusion using ASL can be seen in reports from the litera-
ure, where typical values are in the range 30–40 ml/100 g/min, e.g.
Petersen et al., 2010), lower than the expected GM perfusion of 50–
0 ml/100 g/min. Whilst this consequence of PVE might be consistent
ithin a study population, since an average value is being taken across
any voxels each affected by PVE, in practice there will be systematic
ifferences between populations due to anatomy (e.g. due to increasing
trophy with age and pathology). There will also be systematic differ-
nces between studies since no one consistent approach is taken to de-
ne GM voxels, e.g., differences in methods for segmentation and the
ource of partial volume estimates. In practice, it is common for the de-
ails related to the definition of the GM ROI to be incompletely reported,
eaning that it isn’t even possible to establish whether there might be
ystemic differences between studies. 
.2. The influence of PVE on voxelwise perfusion statistics 
Partial volume effects are particularly problematic when voxelwise
tatistical tests are applied across groups of individuals. Group analy-
is normally includes the additional step of spatial normalization from
ubject image space to a template image space, e.g., MNI152. Whilst spa-
ial normalization might be able, under ideal conditions, to align sulci
nd gyri between individuals and thus match voxels across the group, it
annot overcome PVE present within the original ASL data. The conse-
uences of PVE on detecting voxelwise perfusion differences are: 
• in each individual, a different mixture of tissues will have been cap-
tured in spatially equivalent voxels, leading to differences in perfu-
M.A. Chappell, F.A.K. McConnell, X. Golay et al. NeuroImage 238 (2021) 118236 
Fig. 2. Variability in brain structure across a group as 
a source of potential variability in apparent perfusion. 
The images show a) the mean PV of GM and b) the vari- 
ability in the PV of GM (expressed as the standard de- 
viation) across a group of 14,503 individuals from the 
UK Biobank Imaging study. For methodological details 






























o  sion values on an individual level that directly reflect the mixture
of tissues present within the measurement voxel, for example in a
voxel identified within the GM based on segmentation there will be
an underestimation of perfusion related to the contribution of CSF
and WM tissue; 
• a reduction in statistical power (false negatives) to detect differences
due to added variability in apparent perfusion that arise purely from
PVE. 
• false positive findings due to consistent differences in PVE between
groups (e.g. due to sex) thereby indicating statistically significant
differences, whereas the perfusion within individual tissues is not
different between the groups. 
This effect is illustrated in Fig. 2 , which shows the variability in the
roportion of GM tissue within voxels across 14,503 individuals from
he UK Biobank Imaging Study ( Miller et al., 2016 ) when transformed
nto MNI152 (2 mm) template image space. The standard deviation map
n Fig. 2 reflects the variability due to PVE alone, and largely arises4 rom a mismatch in PVE in the original ASL data due to differences
n underlying brain structure (although additional variability will also
e introduced by imperfect spatial normalization algorithms ( Petr et al.,
013 ). This variability, which is over 30% in regions of cortical GM, will
ranslate directly into variability in the apparent perfusion within the
oxel and hence additional variability in any statistical analysis and the
tatistical power available to detect genuine perfusion differences. Sep-
rately, differences in PVE between groups occur through variation in
natomy and will give rise to a systemic difference in apparent perfusion
n affected brain regions. These have been shown to make a measurable
ontribution to age-related perfusion changes, for example, accounting
or an apparent 10–12% increase in the age-related perfusion difference
etween men and women ( Asllani et al., 2009 ). 
.3. The influence of PVE when coincident with atrophy 
With the use of ASL in clinical applications, it became evident early
n that partial volume effect could be a major confound in studies of



























































Fig. 3. Variation in the percentage of brain voxels that count as ‘pure’ GM for 
different thresholds on the downsampled PV estimate for the data in Fig. 1 . 
Shown above the plot are corresponding images for the ROI created by that 







































ging and dementia ( Johnson et al., 2005 ). This was, in part, due to the
arallel discussion in PET-literature of the influence of PVE on FDG- and
 
15 -PET studies ( Meltzer et al., 2000 ; Samuraki et al., 2007 ). Atrophy
s present in aging and has been observed in many neurological and
sychiatric disorders ( Pini et al., 2016 ). Given the influence of PVE on
erfusion images, it is possible to observe apparent perfusion changes
etween groups that arise from atrophy alone. Moreover, in atrophic
egions loss of GM might mask true physiological changes in cortical
erfusion. 
The consequences of PVE on detecting genuine perfusion changes
hen accompanied by atrophy are: 
• Systematic differences between groups due to underlying differences
in GM volumes that are a direct consequence of pathology leading to
misinterpretation of hemodynamic alterations from ASL data where
structural changes are the true underlying cause of the signal change.
• Masking of potential compensatory increases in perfusion in regions
of GM atrophy ( Alsop et al., 2008 ). 
• Potential overestimation of hypoperfusion in regions where both
perfusion and GM volume are reduced. While this could be help-
ful for identification of pathological changes, the combined loss of
GM and decreased perfusion is typically associated with more severe
pathology such as later stages of dementias. 
Reductions in cortical volume of ~0.5% per year have been observed
n healthy aging, with more pronounced changes in Alzheimer’s disease
 Fjell et al., 2009 ), which would directly translate into a similar order
f magnitude reduction in apparent perfusion. In practice, there is evi-
ence for a complex relationship between changes in atrophy in perfu-
ion with age and in disease disease ( Chen et al., 2011 ; Chen et al., 2012 )
otentially reflecting both apparent and genuine changes in perfusion.
n a clinical diagnostic context, the apparent enhancement of pathologi-
al regions due to atrophy combined with hypoperfusion might be help-
ul to increase the sensitivity for identification of affected regions as a
erfusion-based biomarker for neurodegeneration. From both a clinical
nd research perspective, information on both functional (hypo- and
yper-perfusion) and structural (atrophy) disease processes is still po-
entially relevant for diagnostic and disease progression purposes. Thus,
lthough areas of atrophy but normal perfusion are very common in ag-
ng, areas of perfusion change without atrophy might indicate the early
tages of disease progression in dementias. Being able to separate true
M hypoperfusion from apparent hypoperfusion due to atrophy might
elp distinguish, at an early stage, pathology from normal age-induced
hanges. 
. Managing PVE in ASL studies 
In this section we examine strategies that can be used to manage the
nfluence of PVE in studies that employ ASL, particularly the value of
orrection methods. We seek to make recommendations based on usage
n the literature and our experience using these techniques. 
.1. Restricting analysis to only gray matter voxels 
A simple solution to PVE that has been adopted in the literature is to
nly include voxels identified as being within the GM, normally based
n the segmentation of an anatomical image. For ROI-based analysis
his involves further restricting the ROI, for a voxelwise analysis this
nvolves a restriction on which voxels contribute to the group analysis
hich might be implemented on a subject-by-subject basis or based on
n average (e.g. atlas based) definition of where GM is present. The most
ommon example of restricting analysis is the definition of whole-brain
M perfusion as discussed in 2.1, but this approach has also been used
ith other atlas defined anatomical regions. 
Substantial variation is seen in the literature as to how this restric-
ion is implemented and often details needed to reproduce the process5 re missing. Segmentation algorithms, as applied to an anatomical im-
ge, may produce any combination of a GM segmentation, indicating
oxels where GM is present or the dominant tissue type; a map of the
robability of GM being present in each voxel; and a map of partial vol-
me estimates of GM within each voxel. The use of either of the latter
wo maps requiring the choice of a threshold to define which voxels
ill be counted as GM. Additionally, this segmentation will have been
erformed at the resolution of the anatomical image and thus either the
erfusion image will need to be up-sampled to the grid of the anatomical
mage, or the GM information down-sampled onto the grid of the ASL
ata. Each of these choices, and the algorithm used, potentially leading
o subtly different definitions of the final restricted set of GM voxels. 
As already noted, it is practically impossible to define ‘pure’ GM vox-
ls for ASL given the typical data resolution. Fig. 3 illustrates this issue
hen using a threshold on the GM PV estimate to define a whole-brain
M ROI for the data shown in Fig. 1 . Choosing a high threshold to ex-
lude WM and CSF partial volumes leads to very few remaining voxels
hat they are unlikely to be truly representative of the whole brain; us-
ng a lower threshold leads to a more plausible mask but there will be
esidual contamination with other tissues. In practice, therefore, it is
ecessary to choose a pragmatic threshold on GM PV estimate and thus
here will remain some degree of PVE in the resulting analysis. The pro-
ess of restricting to GM voxels could also lead to systematic differences
ased on variation in the cortical thickness of different brain regions or
n different populations. Regions or individuals with thicker cortex will
ave a higher proportion of GM and thus contribute more voxels to the
esulting GM mask. 
Overall, we would not advocate this approach to managing PVE in
SL since at best it only reduces and cannot eliminate PVE. However,
iven that there might exist situations where correction for PVE (to be
iscussed in the next section) might not be feasible, we make some rec-
mmendations on how this approach could be used in a way that min-
mizes systematic differences and offers transparency and reproducibil-
ty. 
• GM ROIs should be defined in terms of a partial volume estimate,
where available, or failing that, the probability of GM tissue in the
voxel. A GM segmentation image (a binary mask produced by the
segmentation algorithm which will indicate voxels in which GM is
the dominant tissue) should not be used to control for PVE. 























































































































i  • A threshold of 70% GM partial volume should be used to define
‘pure’ GM. The > 70% threshold recommended here is a pragmatic
and conservative choice reflecting the comparatively low resolution
of typical ASL data compared to cortical thickness. As can be seen
from Fig. 3 this leads to a mask that samples GM perfusion from
across the brain, even if it is sparse compared to the voxels that con-
tain some GM tissue. This pragmatic threshold could still lead to a
bias, across regions of the brain, or between particular individuals,
with those with thicker cortex, contributing more voxels for the cal-
culation of the ROI perfusion. 
• Studies should specifically report on the process via which the GM
is identified, including: the algorithm used to arrive at PV estimates;
the method used to down-sample these estimates or up-sample the
perfusion image (including how registration was performed to arrive
at any transformations between image spaces, and the interpolation
method used); the PV threshold used. Where data sharing permits,
the perfusion images and associated partial volume maps should be
made available alongside the report of a study. 
.2. Partial volume effect correction 
Various PVE correction (PVEc) methods have been specifically de-
eloped for ASL to overcome the mixed tissue problem and directly
stimate pure GM (and in some cases WM) perfusion at each voxel
ithin the brain. Early methods assumed constant WM perfusion or
onstant (both spatially as well as between subjects) ratios of WM/GM
erfusion values ( Johnson et al., 2005 ; Villain et al., 2008 ). More re-
ently ‘spatially regularized’ approaches have been developed based
n the assumption that, in a small neighbourhood, perfusion in ‘pure’
ray matter is constant ( Ahlgren et al., 2014 ; Asllani et al., 2008 ;
happell et al., 2011 ; Kandel et al., 2015 ; Liang et al., 2013 ; Petr et al.,
013 ; Wiersma et al., 2006 ) (these are discussed in more depth in ‘Cor-
ecting for Partial Volume Effects’ in the Supplementary Materials). By
nalyzing neighbouring voxels and assuming constant perfusion of each
issue type, the perfusion of the different tissue types can be estimated
y exploiting the variation in partial volume fractions from one voxel
o the next. Borogovac et al. ( Borogovac et al., 2010 ) examined the sen-
itivity of ASL to map brain function over an extended time period and
ound increased sensitivity to CBF changes using PVEc. However, there
s little other systematic literature that examines whether this poten-
ial advantage translates into improved statistical power for detection
f subtle differences in perfusion more generally. There are also poten-
ial drawbacks of these PVE correction methods. These methods over-
implify physiological variability within the subject and also may lead
o spatial smoothing of the data, potentially reducing spatial specificity.
oreover, these methods lead to increases in noise, an inherent effect
f estimating more than one perfusion value from a single set of data at
ach voxel. PVEc methods are also dependent upon the accuracy of the
artial volume estimates and are thus subject to errors associated with
he source images for these (normally anatomical imaging) and the algo-
ithms used to make these estimates (as discussed further in ‘Confounds
or PVEc’ in the Supplementary Materials). 
While PVEc methods are increasingly available in ASL analysis tools,
here is limited experience with their use in the literature. Based on this,
e recommend that: 
• Studies should attempt partial volume correction in addition to per-
forming their analysis without the correction (or vice versa). 
• Correction should use a spatially regularized method to avoid im-
posing strict assumptions on perfusion values in the data (for more
details on PVEc methods see ‘Correction for Partial Volume Effects’
found in the Supplementary Materials). 
• Where partial volume estimates are defined at a higher resolution
than the ASL data, e.g. from the segmentation of a structural image,
they should be transformed into the lower resolution of the ASL data
by a method that sums the tissue contributions within the voxels, not6 by simple linear interpolation (for more details see ‘Transforming
higher resolution partial volume estimates to ASL resolution‘ found
in the Supplementary Materials) 
• Care should be taken when comparing results with and without
PVEc, but differences should motivate further investigation into how
PVE or PVEc affect the results of group analysis. 
It might be unusual to advocate performing two analyses of data, and
t is important that account is taken of the resulting multiple compar-
sons and that both analyses are reported. But we believe it is justified
iven the potential influence of PVE on perfusion, as well as the interpre-
ation of the findings and hence on the conclusions drawn from an ASL
tudy. Moreover, by also reporting non-PVEc values comparison with
urrent body of literature remains possible. Alongside a wider use of
VEc, further work is required to validate PVEc results using model sys-
ems in which it is possible to make tissue specific, potentially invasive,
erfusion measurements. 
.3. Additional considerations when atrophy is present 
Early studies using FDG-PET have demonstrated, using a ratio-based
artial volume correction method, apparent hypometabolism indepen-
ent of atrophy in Alzheimer’s Disease ( Villain et al., 2008 ). While
ome studies have found a substantial difference in the results ob-
ained with and without correction for PVE in ASL ( Borogovac et al.,
010 ; Steketee et al., 2015 ), others have detected only subtle differ-
nces ( Abad et al., 2016 ; Binnewijzend et al., 2013 ). Some studies have
sed anatomical parameters (tissue volume extracted from partial vol-
me estimates or cortical thickness) as regressors in the analysis of the
ncorrected CBF images. Using cortical thickness as a regressor, ( Chen
t al., 2011 ), found only “subtle ” difference in the results, suggesting
 minor dissociation between CBF and anatomical changes in the brain
ue to aging. However, regressor based approaches to account for PVE
re not the same as PVEc, and it is thus more difficult to draw conclu-
ions from them about the utility of partial volume correction in ASL
erfusion imaging of disease. 
Whilst there is more literature addressing PVE in the study of perfu-
ion changes in disease where changes in GM volume are expected, there
s no clear consensus on how to manage PVE and thus whether PVEc is
arranted. Given the potential bias associated with restricting analy-
is to GM voxels as discussed in Section 3.1 , this approach wouldn’t be
ppropriate in the context of anatomical difference or change. Hence,
ur recommendations would be to use PVEc, following the approach
utlined in Section 3.2 and undertaking analysis with and without cor-
ection for PVE. In this case, it is critical to examine differences in the
esults between these two analyses and determine whether they can be
ttributed to differences in GM partial volume. 
An emerging alternative to PVEc for the detection of abnormal per-
usion in an individual is to attempt to predict a personalized ‘normal’
erfusion map based on anatomical data. For example, Kandel et al.
2015 ) attempted to model the relationship between anatomy and per-
usion using a general linear model that included as regressors the par-
ial volume estimates along with other image-derived features. It is too
arly to make any recommendations for the use of such an approach and
here are ongoing projects evaluating similar methodologies. However,
he approach might in the future represent an alternative to attempt-
ng to correct the perfusion image for partial volume effects, offering
ore sensitivity to detect perfusion changes in an individual, for exam-
le pathological changes in a patient. 
. Conclusion 
The partial volume effect results in systematic underreporting of gray
atter perfusion in ASL studies due to the presence of other, less per-
used, tissues within ROIs and individual voxels. PVE is a substantial,
nd often overlooked issue, particularly when ASL is used in group stud-
es and/or clinical populations. Use of GM masking is at best only a





















































































































artial solution and must be accompanied by consistent, comprehensive
eporting. Experimental results to date have not shown a consistent ben-
fit of correction for PVE, but a variety of methods have been employed
n only a small number of studies. The strong conceptual argument for
VE correction, and the ongoing improvement in methods motivate con-
inued evaluation, especially in studies of older or diseased populations
here atrophy is expected. Greater use of correction, alongside conven-
ional analyses, and more systematic studies of the influence of PVE and
erits of correction are required for the field to move forward in this
rea and form the basis of a future consensus. Hence, we recommend
hat studies should attempt and report on the result of partial volume
orrection in addition to performing their analysis without the correc-
ion (or vice versa). 
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